-
2025-521514-26-00
5
2026-01-26
Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer W
-
2025-521352-38-00
5
2026-01-16
Hereditary Angioedema
-
2023-507525-42-00
5
2025-12-23
Endometrial cancer
-
2024-518899-31-00
5
2025-12-19
Variant or wild-type transthyretin (TTR) amyloid cardiomyopathy
-
2024-517393-13-00
4
2025-12-02
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
-
2025-520998-39-00
5
2025-11-07
Congenital pseudarthrosis of the tibia
-
2024-514695-41-00
5
2025-10-17
Ulcerative Colitis
-
2023-508804-39-00
5
2025-10-15
Ulcerative Colitis or Crohn’s Disease
-
2023-508056-19-00
5
2025-10-02
HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient (pMMR), P
-
2024-518589-29-00
5
2025-08-21
Bronchiectasis
-
2024-512753-24-00
5
2025-08-05
Acute Myeloid Leukemia (AML)
-
2024-518973-32-00
5
2025-07-03
Chronic Graft-Versus-Host Disease
-
2024-512360-55-00
4
2025-06-30
Unresectable locally recurrent or metastatic hormone receptor (HR)-pos
-
2024-511166-36-00
5
2025-06-13
Moderate to Severe Plaque Psoriasis
-
2023-504478-39-00
5
2025-05-23
Squamous cell carcinoma of head and neck
-
2023-507936-20-00
5
2025-05-05
Acute myeloid leukemia
-
2024-511239-91-00
4
2025-05-05
Resectable Stage I-III Non-Small Cell Lung Cancer (NSCLC)
-
2024-513054-30-00
5
2025-04-16
Moderately to Severely Active Crohn's Disease (CD)
-
2024-512659-19-00
10
2025-03-31
Advanced Melanoma
-
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
-
2024-515506-11-00
4
2025-03-24
Urothelial Carcinoma
-
2024-513018-36-00
5
2025-03-06
Lung Diseases, Interstitial
-
2024-511470-79-00
6
2025-02-11
Rheumatoid Arthritis
-
2023-503188-40-00
5
2025-01-06
Active Ulcerative Colitis or Crohn’s Disease